MSTN and neoplasm: In animal models, the LJFE‐E‐injected C26 tumor‐bearing group showed lower transcript‐level expression of MSTN, MuRF1, and MAFbx32 in the gastrocnemius muscles than the C26 tumor‐bearing group.